Biomarker Expression Can Identify Biologically Distinct Categories of Invasive Breast Cancer

被引：0
|
作者：
Shim, J. Y.
Zhou, R.
Thompson, P. A.
Brewster, A. M.
Murray, J. L.
Edgerton, M. E.
Karadag, N.
Bondy, M. L.
Sahin, A.
机构：
[1] Univ Texas Houston, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Arizona Canc Ctr, Tueson, AZ USA
来源：
LABORATORY INVESTIGATION | 2010年 / 90卷
关键词：
D O I：
暂无
中图分类号：
R-3 [医学研究方法]; R3 [基础医学];
学科分类号：
1001 ;
摘要：
312
引用
收藏
页码：72A / 72A
页数：1
相关论文
共 50 条
  • [31] Mesothelin expression as a predictive biomarker of breast cancer outcomes
    Li, Yun Rose
    Xian, Rena R.
    Ziober, Amy
    Conejo-Garcia, Jose
    June, Carl H.
    Zhang, Paul J.
    Tchou, Julia C.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (15)
  • [32] Distinct expression profiles and functions of Kindlins in breast cancer
    Azorin, Paula
    Bonin, Florian
    Moukachar, Ahmad
    Ponceau, Aurelie
    Vacher, Sophie
    Bieche, Ivan
    Marangoni, Elisabetta
    Fuhrmann, Laetitia
    Vincent-Salomon, Anne
    Lidereau, Rosette
    Driouch, Keltouma
    JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH, 2018, 37 : 1 - 15
  • [33] Distinct expression profiles and functions of Kindlins in breast cancer
    Paula Azorin
    Florian Bonin
    Ahmad Moukachar
    Aurélie Ponceau
    Sophie Vacher
    Ivan Bièche
    Elisabetta Marangoni
    Laetitia Fuhrmann
    Anne Vincent-Salomon
    Rosette Lidereau
    Keltouma Driouch
    Journal of Experimental & Clinical Cancer Research, 37
  • [34] Upregulated Tie2 expression in plasma: a potential non-invasive biomarker for the diagnosis of breast cancer
    Qingzhu Song
    Fenglan Zhang
    Tian Yuan
    Yulong Wei
    European Cytokine Network, 2021, 32 : 39 - 47
  • [35] Upregulated Tie2 expression in plasma: a potential non-invasive biomarker for the diagnosis of breast cancer
    Song, Qingzhu
    Zhang, Fenglan
    Yuan, Tian
    Wei, Yulong
    EUROPEAN CYTOKINE NETWORK, 2021, 32 (02) : 39 - 47
  • [36] Distinct patterns of biomarker expression for atypical intraductal proliferations in prostate cancer
    Martini, Carmela
    Logan, Jessica M.
    Sorvina, Alexandra
    Prabhakaran, Sarita
    Ung, Benjamin S. Y.
    Johnson, Ian R. D.
    Hickey, Shane M.
    Brooks, Robert D.
    Caruso, Maria C.
    Klebe, Sonja
    Karageorgos, Litsa
    O'Leary, John J.
    Delahunt, Brett
    Samaratunga, Hemamali
    Brooks, Douglas A.
    VIRCHOWS ARCHIV, 2024, 485 (04) : 723 - 728
  • [37] Investigation of transglutaminase 2 as a biomarker of invasive breast cancer that is likely to metastasise
    Blows, Fiona
    Provenzano, Elena
    Ali, Raza
    Cope, Wei
    Pharoah, Paul
    Pike, Claire
    Coussons, Peter
    BRITISH JOURNAL OF CANCER, 2018, 119 (11) : 31 - 31
  • [38] miR-320a is an independent prognostic biomarker for invasive breast cancer
    Yang, Haiping
    Yu, Juan
    Wang, Lei
    Ding, Di
    Zhang, Lei
    Chu, Chengyu
    Chen, Qi
    Xu, Zude
    Zou, Qiang
    Liu, Xiuping
    ONCOLOGY LETTERS, 2014, 8 (03) : 1043 - 1050
  • [39] Using a cell line breast cancer progression system to identify biomarker candidates
    Yen, Ten-Yang
    Haste, Nicole
    Timpe, Leslie C.
    Litsakos-Cheung, Christina
    Yen, Roger
    Macher, Bruce A.
    JOURNAL OF PROTEOMICS, 2014, 96 : 173 - 183
  • [40] Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy
    Luveta, Jocelyn
    Parks, Ruth M.
    Heery, David M.
    Cheung, Kwok-Leung
    Johnston, Simon J.
    ONCOLOGY AND THERAPY, 2020, 8 (01) : 1 - 11
12345